Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from diabetes

The supplement that could help with weight loss for people with diabetes

Turmeric and curcumin may offer modest benefits for weight management in people with prediabetes and type 2 diabetes, a new study found

The Independent UK

Diabetes patients could be offered weight loss jabs sooner in major shake-up

The changes will impact millions of people with type 2 diabetes in England in the biggest shake-up of care in a decade

The Independent UK

Type 2 diabetes patients set for major shake-up in care

New draft guidance from the National Institute for Health and Care Excellence suggests the NHS should move away from a one-size-fits-all approach.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk

Health Canada on Tuesday approved Novo Nordisk's (NYSE:NVO) Ozempic (semaglutide) to reduce the risk of kidney disease and cardiovascular deaths in adults with type 2 diabetes.

Benzinga

Continuous glucose monitors: should people who don’t live with diabetes be wearing them?

Gwyneth Paltrow and other celebrities and influencers are sporting CGMs, but counting your glucose levels provides little benefit if you don’t have diabetes

The Guardian - AU

Half-off Ozempic? US patients paying in cash can now buy the popular weight-loss drug for less

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes patients

The Independent UK

Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients

The previous out-of-pocket price was nearly $1,000.

Fortune

Read news from The Economist, FT, and more,
with one subscription

New study finally busts health myth of much-loved tropical fruit

Clinical trials replaced breakfast bread with a mango and monitored glycemic responses

The Independent UK

Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst

On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom.

Benzinga

Mounjaro Is About to Get More Expensive in the UK: Here Are Cheaper Alternatives Available Right Now

Mounjaro's UK price will rise by 170% in September, prompting interest in cheaper alternatives like semaglutide for weight loss.

International Business Times UK

Ozempic didn’t work for me. I was furious – and ashamed

Everyone taking the ‘skinny shot’ was losing weight, but my scales didn’t change. My inner dialogue became toxic

The Guardian - US

Breakthrough drug that slows onset of type 1 diabetes set for UK release

Teplizumab can allow patients to live “normal lives” without the need for insulin injections

The Independent UK

Drug that slows onset of type 1 diabetes licensed for use in UK-first

The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care Excellence.

Evening Standard

Eli Lilly To Raise Mounjaro Price In UK, Expands Obesity Drug Push In India

Eli Lilly and Co. (NYSE:LLY) will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom, while expanding its market presence in India with a new injector pen.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

LiveScience

Diabetic man produces his own insulin after gene-edited cell transplant

The new proof-of-concept study points a way to curing diabetes without the need for immune-suppressing drugs.

Benzinga

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant of bribing medical providers to promote its most profitable drugs, including the widely used GLP-1 medications Mounjaro and Zepbound for diabetes and weight loss.

The Independent UK

The lifestyle medicine that could clear menopausal brain fog

Lifestyle medicine uses interventions to prevent and manage chronic conditions such as heart disease, diabetes and dementia

The Independent UK

Study links weight-loss drugs to serious eye conditions and vision loss

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye complications

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Ozempic and other weight-loss drugs linked to rare but serious eye conditions

Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage diabetes and obesity around the world.

MarketBeat

Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly

Trump’s plan to cover weight loss drugs under Medicaid programs and Medicare Part D plans to could be a major tailwind for LLY and NVO, despite tarrif threats.

The Independent UK

The ‘small, sustainable changes’ that support your long-term health

IN FULL

Budget and the Bees

10 Foods That Help Burn Belly Fat Naturally

Stubborn belly fat, also known as visceral fat, is more than just a cosmetic concern; it’s a key risk factor for serious health issues like heart disease and type 2 diabetes. While spot reduction is a myth, you can significantly reduce abdominal fat by adopting a healthy lifestyle that includes…

Euronews

Portugal tightens rules on weight loss drug prescriptions to prevent misuse

Doctors from only four medical specialties will be able to write prescriptions for injectable drugs that are used to treat type 2 diabetes and obesity but are also popular for weight loss.

The Independent UK

The easy food swaps you should make today to reduce the risk of type 2 diabetes

People who eat French fries three times a week face a 20 per cent greater risk of developing diabetes

Benzinga

Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock

Tandem Diabetes Care Inc.’s (NASDAQ:TNDM) stock plunged on Thursday after the company cut its annual guidance.

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.